http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2747942-C
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-475 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2009-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59c4b8bc33a1a073a13ba86a356a022e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e90c8de9081b0df23ba889110e41a6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c85b3ad654c9e38ad506759fadb41476 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bce07da94088df04739f3db6bdf687d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_348c0d72a2e01c15ca60ea8380cc0d91 |
publicationDate | 2016-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2747942-C |
titleOfInvention | Armet as a marker for cancer |
abstract | The present invention relates to a method aiding in the assessment of cancer. It dis-closes the use of the arginine-rich metastasized in early tumors protein (= ARMET) as a universal marker of different cancer types. ARMET aids in the assessment of pulmonary or lung cancer (LC) or of colon cancer, e.g. of non-small cell lung car-cinoma (NSCLC) or colorectal cancer (CRC), but also likely of other specific types of cancer. Such specific cancer types are e.g. breast, ovary, cervix, head and neck, endometrium, melanoma, bladder, kidney, pancreas, prostate, esophagus, stomach or bile duct cancer. Furthermore, it especially relates to a method for assessing cancer from a liquid sample, derived from an individual by measuring ARMET in said sample. Measurement of ARMET can, e.g., be used in the early detection of cancer or in the surveillance of patients who undergo surgery. |
priorityDate | 2008-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 114.